Apply

GTH-B

Global Training Hub for Biomanufacturing

AVSSR Vaccine Human Resource Development Program 2024

The AVSSR (ASEAN Vaccine Security and Self-Reliance) initiative presents a comprehensive training program aimed at strengthening vaccine development and deployment capacities across ASEAN. Participants will explore cutting-edge vaccine technologies, regulatory harmonization, and strategies to address vaccine hesitancy. Led by industry experts, this immersive experience combines lectures, workshops, and collaborative discussions, empowering participants to enhance regional healthcare cooperation and support vaccine security and self-reliance across ASEAN.

IVI Online Campus

The IVI Online Campus aims at strengthening the technical knowledge and expertise in manufacturing high-quality vaccines and biologics. Our online training program makes the GTH-B expertise in biomanufacturing and biologics development available anytime, anywhere, and with free access for all.

2024 Introductory Course for Biologics Development and Manufacturing

This two-week course held on-site in South Korea, 2024 June, offers primary knowledge in all areas related to biologics manufacturing, including the pre-clinical and clinical development stage, manufacturing processes, quality control and assessment, and regulatory affairs.

Through IVI, the GTH-B has already run two editions of this introductory course as well as the Introductory Course for Standard Practice (GxP), training nearly 500 professionals from 40+ countries since 2022.

2024 Introductory Course for Standard Practice (GxP)​

Stay tuned for the GxP course happening later this fall!

The course will equip participants with essential skills based on good biomanufacturing practices. It will be conducted in-person in Seoul over 3 weeks and will include didactic and practice sessions on Good Laboratory Practice, Good Clinical Practice, Good Clinical Laboratory Practice, Good Manufacturing Practice, and Biosafety.
Previous slide
Next slide

news

IVI to conduct ‘2024 Introductory Course for Biologics Development and Manufacturing’ to help address global vaccine inequity

June 3, 2024, SEOUL, Republic of Korea — International Vaccine Institute (IVI) announced it will conduct the ‘2024 Introductory Course for Biologics Development and Manufacturing’ as part of the Global Training Hub

Read More

IVI conducts ‘2023 Introductory Course for Standard Practice (GxP Course)’ to support LMICs in local biomanufacturing

October 30, 2023, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) is conducting the Introductory Course for Standard Practice (GxP Course) for a total of 180 participants, including 148 trainees from

Read More

IVI conducts 2nd Introductory Course for Biologics Development and Manufacturing for 235 trainees from 47 LMICs

June 19, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is conducting the 2023 Introductory Course for Biologics Development and Manufacturing for bio-R&D and production personnel from

Read More

IVI conducts 1st Introductory Course for Standard Practice (GxP Course) Oct. 31 – Nov. 18

October 31, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) kicked off the ‘Introductory Course for Standard Practice (GxP Course)’ on October 31 at Seoul National University’s

Read More

IVI to conduct ‘2024 Introductory Course for Biologics Development and Manufacturing’ to help address global vaccine inequity

June 3, 2024, SEOUL, Republic of Korea — International Vaccine Institute (IVI) announced it will conduct the ‘2024 Introductory Course for Biologics Development and Manufacturing’ as part of the Global Training Hub for Biomanufacturing (GTH-B) program at Seoul National University’s Siheung Campus for two weeks starting June 3.
Read More
IVI conducts ‘2023 Introductory Course for Standard Practice (GxP Course)’ to support LMICs in local biomanufacturing
October 30, 2023, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) is conducting the Introductory Course for Standard Practice (GxP Course) for a total of 180 participants, including 148 trainees from 44 low- and middle-income countries (LMICs) and 32 Koreans, for three weeks from October 30.
Read More

IVI conducts 2nd Introductory Course for Biologics Development and Manufacturing for 235 trainees from 47 LMICs

June 19, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is conducting the 2023 Introductory Course for Biologics Development and Manufacturing for bio-R&D and production personnel from low- and middle-income countries (LMICs).
Read More

IVI conducts 1st Introductory Course for Standard Practice (GxP Course) Oct. 31 – Nov. 18

October 31, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) kicked off the ‘Introductory Course for Standard Practice (GxP Course)’ on October 31 at Seoul National University’s Shiheung Campus to train 230 trainees from 33 low- and middle-income countries (LMICs) and 42 from Korea.
Read More

Most View Session

Introductory cGMP Part 1

  • GMP
  • 1Hour
  • Gustavo Mendes Lima Santos

Introduction to Good Laboratory Practice (GLP)

  • GLP
  • 1Hour 20Min
  • Tobin C. Guarnacci

Basic Statistics for Clinical Research

  • Clinical Development
  • 1Hour
  • Deok Ryun Kim

Biosafety Overview Part 1

  • Biosafety
  • 45Min
  • Vaishali Yardi

Biosafety Overview Part 2

  • GMP
  • 1Hour
  • Gustavo Mendes Lima Santos

Quality by Design for Vaccines – Role of Process Analytical Technologies (1)

  • Development
  • 45Min
  • Gautam Sanyal

MEDIA

Global Training Hub for Biomanufacturing (GTH-B)

Highlights of 2023 Introductory Course for Biologics Development and Manufacturing

gallery

see in numbers GTH-B

0
Total Users
0
total online course sessions
0
TOTAL BADGES
0
Taking an online course

FOLLOW Us

Facebook Twitter Youtube Linkedin Instagram

contact us

Email : gthb.coordinator@ivi.int

Partners

Apply